PhagenCorp | World-Leading Provider of Phage Therapy
Targeted Application of the Body’s Native Intelligence
At PhagenCorp, we empower doctors and healthcare providers with ground-breaking phage therapies. Our proprietary Inducen® formulas are designed to activate and support the body’s natural healing abilities, helping the body do more of what it was designed to do.
Applications: Gut Health • Lyme Disease • CIRS • Infections • Respiratory Disease • Dental Issues • And More
Join Our Growing Movement of Phage Therapy Providers
Across the world, healthcare professionals are looking for more effective treatments for their patients. Antibiotics, traditional phage therapy, and even supplements can fall short. But Induced Native Phage Therapy bypasses many pitfalls associated with other care options.
Now is your chance to offer a therapy that your competitors don’t offer. Get one step ahead. Become a certified provider today.
What Is Induced Native Phage Therapy (INPT)?
Your body contains over 30,000 populations of naturally occurring bacteriophages—tiny, virus-like elements that are part of your microbiome from birth and work alongside the immune system to help maintain microbial equilibrium.
INPT, or Induced Native Phage Technology, is a proprietary method developed by PhagenCorp to selectively activate native phage populations using low-frequency electromagnetic signatures. These signals are imprinted into an oral solution containing trace nanoparticle elements, allowing targeted informational delivery to the body’s internal microbial regulation systems.
This is not a supplement. Not a pharmaceutical. And not a probiotic. It is a signal-based modality—entirely non-chemical, biologically gentle, and designed to interface with the body’s innate systems without disruption.
Introducing the Inducen® Formula Line. Phage Therapy Applied
The Inducen® formulas are the first application of INPT, representing over a decade of research and refinement. Each formula contains dozens of precisely tuned electromagnetic signatures selected to encourage phage responses related to specific microbial terrains—ranging from the gastrointestinal tract and skin to the nervous system and vascular tissues.
To date, over 200,000 doses of Inducen® have been administered in IRB-supported clinical research with no reported adverse effects—including in patients with complex sensitivities.
Each formula is non-toxic, non-allergenic, and supports the body without interfering with other therapies or beneficial flora. While these products are not intended to treat or cure disease, they offer a forward-thinking method for working with the body—not on it.
Lyme Disease & Tick-Borne Illness
Lyme disease and other vector-borne illnesses can involve complex microbial challenges that persist over time. Inducen®-LD/RF phage therapy is designed to stimulate key native phages that target bacterial populations associated with Borrelia, relapsing fever, and other microbes commonly associated with tick-borne disease.
Respiratory, Ear, Eye & Throat Conditions
Recurring or persistent microbial issues can affect the respiratory tract, sinuses, ears, eyes, and throat. Inducen®-RES stimulates key native phages that target bacterial and microbial populations associated with these areas.
Brain, Nerve & Neurological Conditions
Microbial activity can sometimes be associated with conditions affecting the brain, spinal cord, and peripheral nerves. Inducen®-CNS is designed to stimulate native phages targeting specific microbial populations associated with the central and peripheral nervous systems.
Gastrointestinal Conditions
Imbalances in bacterial and microbial populations can contribute to a wide range of gastrointestinal concerns. Inducen®-GI targets specific microbial populations associated with issues affecting the gastrointestinal tract.
Urinary Tract Conditions
Urinary tract issues can involve unwanted microbial populations affecting the bladder, kidneys, ureters, or urethra. Inducen®-UTI is designed to stimulate native phages that target specific bacterial and microbial populations associated with the urinary system.
Fungal Conditions
Persistent fungal issues can be difficult to address, particularly when they become chronic or recurrent. Inducen®-MLD stimulates key native phages designed to target specific fungi.
Parasitic Conditions
Certain health concerns may be associated with unwanted parasitic organisms. Inducen-PARA® is designed to stimulate native phages that specifically target selected parasites.
SIBO & SIFO
Small intestinal bacterial overgrowth (SIBO) and small intestinal fungal overgrowth (SIFO) involve excessive microbial populations where they do not belong. Inducen®-SIBO/SIFO targets specific bacterial and fungal populations associated with overgrowth in the small intestine.
Staphylococcal Conditions
Staphylococcus bacteria can be associated with a variety of persistent or recurring health concerns. Inducen-STPH® stimulates key native phages that target specific bacterial populations associated with staphylococcal conditions.
Dental & Oral Health Conditions
Bacterial populations in the mouth can contribute to dental and oral health concerns. Inducen®-DEN is designed to stimulate native phages that target specific bacteria associated with dental issues.
Acne
Certain bacteria can play an important role in the development and persistence of acne. Inducen®-ACNE stimulates native phages designed to target specific bacterial populations associated with acne.
Chronic Inflammatory Response
Chronic inflammatory conditions can sometimes be associated with ongoing microbial stressors. Inducen®-CIRS is designed to stimulate key native phages targeting specific microbes associated with chronic inflammation.
Science, Safety, and Success
-
Over a decade of development
-
Peer-reviewed publication on clinical results
-
200,000+ doses administered
-
No reported adverse events
-
Compatible with most treatment plans
-
Non-interfering and well tolerated—even by hypersensitive populations
How Is INPT Different From Traditional Phage Therapy?
Traditional phage therapy introduces externally sourced bacteriophages into the body to target specific bacteria. Induced Native Phage Technology (INPT) takes a fundamentally different approach.
Instead of introducing outside phages, INPT is designed to stimulate specific native phages already present within the body, encouraging them to become active against targeted microbial populations. Traditional phage therapy brings phages to the body. INPT is designed to activate the phages already within it.
This approach is at the heart of PhagenCorp’s Inducen® technology and our continued exploration of the body’s own microbial ecosystem.
Join Us As We Expand the Frontiers of Biotechnology with Phage Therapy
The future of medicine depends on discovering better ways to work with the biology already within us.
At PhagenCorp, we are advancing biotechnology through continued research into native phages and the body’s natural biological mechanisms. Our work with Inducen® technology represents a new frontier in how targeted microbial challenges may be approached.
We’re continuing to research, innovate, and explore what’s possible. Join us as we push biotechnology forward and work toward a healthier future.
For Licensed Healthcare Providers
PhagenCorp partners exclusively with trained, licensed providers to ensure responsible and informed clinical application.
If you are a physician or healthcare practitioner interested in incorporating INPT into your practice, you may:
- View Product Information – Explore the Inducen® line
- Apply for Access – Create a provider account
- Complete Training – Take a short onboarding assessment
- Place Your Order – Gain access to the practitioner-only store
For Patients and the Public
While Inducen® is not available for direct purchase by consumers, you can explore each formula to better understand how it works and what it supports.
If you are experiencing chronic microbial imbalance or unresolved symptoms and would like to work with a provider trained in Induced Native Phage Technology, we invite you to:
